2012
DOI: 10.1016/j.metabol.2011.11.011
|View full text |Cite
|
Sign up to set email alerts
|

Effects of PKF275-055, a dipeptidyl peptidase–4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E–null mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
71
1

Year Published

2013
2013
2016
2016

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 59 publications
(76 citation statements)
references
References 16 publications
4
71
1
Order By: Relevance
“…Although in our previous studies, DPP-4I and incretins reduced atherosclerotic plaque development in Apoe / mice [8][9][10] , these effects were not observed in Ang -infused Apoe / mice. In this study, DPP- …”
Section: Discussioncontrasting
confidence: 62%
See 1 more Smart Citation
“…Although in our previous studies, DPP-4I and incretins reduced atherosclerotic plaque development in Apoe / mice [8][9][10] , these effects were not observed in Ang -infused Apoe / mice. In this study, DPP- …”
Section: Discussioncontrasting
confidence: 62%
“…Chronic inflammation triggers a cascade of events, such as inflammatory cell invasion, increased cytokine, and chemokine release, and abnormal regulation of extracellular matrix (ECM), ultimately resulting in vascular smooth muscle cell (VSMC) apoptosis and disruption of the elastic lamina 7) . We previously reported that administration of native glucagon-like peptide (GLP)-1, native glucose-dependent insulinotropic polypeptide (GIP), or a dipeptidyl peptidase-4 (DPP-4) inhibitor (DPP-4I) significantly suppressed atherosclerotic lesions in the aortic wall of apolipoprotein E-null (Apoe / ) mice, a representative animal model of atherosclerosis [8][9][10] . Furthermore, incretin-related agents exert antiinflammatory effects in vascular endothelial cells, VSMCs, and monocytes/macrophages 9) .…”
Section: Blood Pressure Measurementsmentioning
confidence: 99%
“…Adding complexity to the vascular effects of GIP, recent studies of dyslipidemic apolipoprotein E knockout mice suggested antiatherogenic effects of GIP or DPP-IV inhibition, apparently via decreased CD36 expression in macrophages and decreased foam cell formation (68)(69)(70). In this mouse model, treatment with GIP significantly reduced plasma nonesterified fatty acid concentrations, which could in part explain the reduced CD36 and macrophage foam cell formation (71).…”
Section: Discussionmentioning
confidence: 85%
“…After the 4-week infusion period, the 21-week-old apoE / mice were anesthetized with diethyl ether, drained of blood via the descending vena cava, and subjected to whole-body perfusion with PBS via a left ventricular cannula 13,[16][17][18][19] . The whole aorta was fixed by perfusion with PBS containing 4 paraformaldehyde, excised from the root to the abdominal area, and carefully stripped of connective and adipose tissues.…”
Section: Assessment Of Atherosclerotic Lesionsmentioning
confidence: 99%